These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3002819)

  • 1. (Na+,K+)-ATPase and noradrenergic regulation: effects of cardiac glycoside treatment and noradrenergic manipulations.
    Swann AC
    Eur J Pharmacol; 1985 Dec; 119(1-2):67-74. PubMed ID: 3002819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute noradrenergic agonist infusions in vivo increase Na+, K+-ATPase and ouabain binding in rat cerebral cortex.
    Swann AC; Steketee JD
    J Neurochem; 1989 May; 52(5):1598-604. PubMed ID: 2540278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Na+, K+)-adenosine triphosphatase regulation by the sympathetic nervous system: effects of noradrenergic stimulation and lesions in vivo.
    Swann AC
    J Pharmacol Exp Ther; 1984 Feb; 228(2):304-11. PubMed ID: 6141282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Na+,K+)-ATPase and noradrenergic function: effects of chronic ethanol.
    Swann AC
    Eur J Pharmacol; 1987 Feb; 134(2):145-53. PubMed ID: 3032651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine.
    Swann AC
    Neuropharmacology; 1988 Mar; 27(3):261-7. PubMed ID: 2836750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain (Na+,K+)-ATPase and noradrenergic function: recovery of enzyme activity after norepinephrine depletion.
    Swann AC
    Brain Res; 1984 Nov; 321(2):323-6. PubMed ID: 6093936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone and norepinephrine: effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart.
    Swann AC
    J Neural Transm; 1988; 71(3):195-205. PubMed ID: 2833573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of brain Na+, K+-ATPase by norepinephrine in vivo: prevention by receptor antagonists and enhancement by repeated stimulation.
    Swann AC
    Brain Res; 1983 Feb; 260(2):338-41. PubMed ID: 6299462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone and adrenalectomy alter brain (Na+,K+)-ATPase responses to noradrenergic stimulation or depletion.
    Swann AC
    Eur J Pharmacol; 1988 Dec; 158(1-2):43-52. PubMed ID: 2851459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noradrenaline and thyroid function regulate (Na+,K+)-adenosine triphosphatase independently in vivo.
    Swann AC
    Eur J Pharmacol; 1989 Oct; 169(2-3):275-83. PubMed ID: 2553449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
    Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
    J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Na+, K+)-ATPase regulation and NaCl intake: effects on circulating inhibitor and sensitivity to noradrenaline.
    Swann AC
    Clin Sci (Lond); 1985 Oct; 69(4):441-7. PubMed ID: 2994940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain (Na+, K+)-ATPase and noradrenergic activity: effects of hyperinnervation and denervation on high-affinity ouabain binding.
    Swann AC; Grant SJ; Maas JW
    J Neurochem; 1982 Mar; 38(3):836-9. PubMed ID: 6173466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Na+,K+-ATPase: alteration of ligand affinities and conformation by chronic ethanol and noradrenergic stimulation in vivo.
    Swann AC
    J Neurochem; 1986 Sep; 47(3):707-14. PubMed ID: 3016182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of desipramine and yohimbine on alpha 2- and beta-adrenoreceptor sensitivity.
    Johnson RW; Reisine T; Spotnitz S; Wiech N; Ursillo R; Yamamura HI
    Eur J Pharmacol; 1980 Oct; 67(1):123-7. PubMed ID: 6252022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood--brain barrier sodium/potassium pump: modulation by central noradrenergic innervation.
    Harik SI
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4067-70. PubMed ID: 3012548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of rat brain alpha- and beta-adrenergic receptor populations by lesion of the dorsal noradrenergic bundle.
    U'Prichard DC; Reisine TD; Mason ST; Fibiger HC; Yamamura HI
    Brain Res; 1980 Apr; 187(1):143-54. PubMed ID: 6244065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
    Schwalb H; Dickstein Y; Heller M
    Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action.
    Kranzhöfer R; Haass M; Kurz T; Richardt G; Schömig A
    Circ Res; 1991 Jun; 68(6):1628-37. PubMed ID: 2036716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.